NanoString Technologies Inc. Launches Early Access Program for New Copy Number Variation Analysis Solution

GOTHENBURG, Sweden & SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the launch of its early access program for a unique new solution that detects copy number variation in human genomic samples. The program was announced in conjunction with the company’s participation in the European Human Genetics Conference in Gothenburg, Sweden.

Back to news